2-(5-((4-butylphenyl)ethynyl)thiophene-2-sulfonamido)-N-hydroxyacetamide

ID: ALA1795351

Chembl Id: CHEMBL1795351

PubChem CID: 53328858

Max Phase: Preclinical

Molecular Formula: C18H20N2O4S2

Molecular Weight: 392.50

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CCCCc1ccc(C#Cc2ccc(S(=O)(=O)NCC(=O)NO)s2)cc1

Standard InChI:  InChI=1S/C18H20N2O4S2/c1-2-3-4-14-5-7-15(8-6-14)9-10-16-11-12-18(25-16)26(23,24)19-13-17(21)20-22/h5-8,11-12,19,22H,2-4,13H2,1H3,(H,20,21)

Standard InChI Key:  YZKJTNXYLZWHHJ-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA1795351

   2-[[5-[2-(4-butylphenyl)ethynyl]thiophen-2-yl]sulfonylamino]-N-hydroxyacetamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 392.50

Molecular Weight (Monoisotopic): 392.0864

AlogP: 2.27

#Rotatable Bonds: 7

Polar Surface Area: 95.50

Molecular Species: NEUTRAL

HBA: 5

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 8.51

CX Basic pKa:

CX LogP: 3.52

CX LogD: 3.49

Aromatic Rings: 2

Heavy Atoms: 26

QED Weighted: 0.38

Np Likeness Score: -0.97

References

1. Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A..  (2011)  Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,  46  (7): [PMID:21514700] [10.1016/j.ejmech.2011.03.033]

Source

Source(1):

• Scientific Literature